HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12

General Information


DRACP ID  DRACP01935

Peptide Name   HEXIM1 (147-164)[K4,5,6,13,14,15R], BR-RRR12

Sequence  QLGRRRHRRRPSRRRRHW

Sequence Length  18

UniProt ID  O94992 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma 25%Killing=100 µM CellTox cytotoxicity assay 30 min 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  HaCat: Not active up to 100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01935

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C104H180N54O21

Absent amino acids  ACDEFIKMNTVY

Common amino acids  R

Mass  282629

Pl  13.45

Basic residues  12

Acidic residues  0

Hydrophobic residues  2

Net charge  12

Boman Index  -15927

Hydrophobicity  -304.44

Aliphatic Index  21.67

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  323.53

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26734838

Title  Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy

Doi 10.18632/oncotarget.6794

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_12675

DRACP is developed by Dr.Zheng's team.